메뉴 건너뛰기




Volumn 104, Issue 10, 2011, Pages 1641-1648

Prolactin receptor is a negative prognostic factor in patients with squamous cell carcinoma of the head and neck

Author keywords

growth factor; head and neck cancer; prognosis; prolactin receptor; proliferation

Indexed keywords

PROLACTIN; PROLACTIN RECEPTOR;

EID: 85027937722     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.131     Document Type: Article
Times cited : (9)

References (43)
  • 1
    • 0033303824 scopus 로고    scopus 로고
    • Prolactin is a survival factor for androgen-deprived rat dorsal and lateral prostate epithelium in organ culture
    • Ahonen TJ, Harkonen PL, Laine J, Rui H, Martikainen PM, Nevalainen MT (1999) Prolactin is a survival factor for androgen-deprived rat dorsal and lateral prostate epithelium in organ culture. Endocrinology 140: 5412-5421
    • (1999) Endocrinology , vol.140 , pp. 5412-5421
    • Ahonen, T.J.1    Harkonen, P.L.2    Laine, J.3    Rui, H.4    Martikainen, P.M.5    Nevalainen, M.T.6
  • 2
    • 0027366454 scopus 로고
    • Characterization of a monoclonal antibody against human prolactin receptors
    • DOI 10.1002/ijc.2910550503
    • Banerjee R, Ginsburg E, Vonderhaar BK (1993) Characterization of a monoclonal antibody against human prolactin receptors. Int J Cancer 55: 712-721 (Pubitemid 23354882)
    • (1993) International Journal of Cancer , vol.55 , Issue.5 , pp. 712-721
    • Banerjee, R.1    Ginsburg, E.2    Vonderhaar, B.K.3
  • 3
    • 0036673766 scopus 로고    scopus 로고
    • Prolactin as an autocrine/paracrine growth factor in human cancer
    • DOI 10.1016/S1043-2760(02)00603-3, PII S1043276002006033
    • Ben-Jonathan N, Liby K, McFarland M, Zinger M (2002) Prolactin as an autocrine/paracrine growth factor in human cancer. Trends Endocrinol Metab 13: 245-250 (Pubitemid 36733969)
    • (2002) Trends in Endocrinology and Metabolism , vol.13 , Issue.6 , pp. 245-250
    • Ben-Jonathan, N.1    Liby, K.2    McFarland, M.3    Zinger, M.4
  • 4
    • 0030451788 scopus 로고    scopus 로고
    • Extra-pituitary prolactin: Distribution, regulation, functions, and clinical aspects
    • Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW (1996) Extra-pituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev 17: 639-669
    • (1996) Endocr Rev , vol.17 , pp. 639-669
    • Ben-Jonathan, N.1    Mershon, J.L.2    Allen, D.L.3    Steinmetz, R.W.4
  • 5
    • 0027283344 scopus 로고
    • Circulating markers and growth factors as prognosticators in men with advanced tongue cancer
    • Bhatavdekar JM, Patel DD, Vora HH, Balar DB (1993) Circulating markers and growth factors as prognosticators in men with advanced tongue cancer. Tumour Biol 14: 55-58 (Pubitemid 23192951)
    • (1993) Tumor Biology , vol.14 , Issue.1 , pp. 55-58
    • Bhatavdekar, J.M.1    Patel, D.D.2    Vora, H.H.3    Balar, D.B.4
  • 6
    • 0033994932 scopus 로고    scopus 로고
    • Prolactin as a local growth promoter in patients with locally advanced tongue cancer: GCRI experience
    • DOI 10.10 02/(SI CI)1097-034 7(2000 05)22:3<25 7::AID-HE D8>3.0.CO;2-K
    • Bhatavdekar JM, Patel DD, Vora HH, Shah NG, Chikhlikar PR, Ghosh N (2000) Prolactin as a local growth promoter in patients with locally advanced tongue cancer: GCRI experience. Head Neck 22: 257-264 (Pubitemid 30215322)
    • (2000) Head and Neck , vol.22 , Issue.3 , pp. 257-264
    • Bhatavdekar, J.M.1    Patel, D.D.2    Vora, H.H.3    Shah, N.G.4    Chikhlikar, P.R.5    Ghosh, N.6
  • 7
    • 33747876154 scopus 로고    scopus 로고
    • Prolactin activates mammalian target-of-rapamycin through phosphatidylinositol 3-kinase and stimulates phosphorylation of p70S6K and 4E-binding protein-1 in lymphoma cells
    • DOI 10.1677/joe.1.06368
    • Bishop JD, Nien WL, Dauphinee SM, Too CK (2006) Prolactin activates mammalian target-of-rapamycin through phosphatidylinositol 3-kinase and stimulates phosphorylation of p70S6K and 4E-binding protein-1 in lymphoma cells. J Endocrinol 190: 307-312 (Pubitemid 44288368)
    • (2006) Journal of Endocrinology , vol.190 , Issue.2 , pp. 307-312
    • Bishop, J.D.1    Nien, W.L.2    Dauphinee, S.M.3    Too, C.K.L.4
  • 8
    • 0023191190 scopus 로고
    • Role of serum in the prolactin responsiveness of MCF-7 human breast cancer cells in long-term tissue culture
    • Biswas R, Vonderhaar BK (1987) Role of serum in the prolactin responsiveness of MCF-7 human breast cancer cells in long-term tissue culture. Cancer Res 47: 3509-3514 (Pubitemid 17096011)
    • (1987) Cancer Research , vol.47 , Issue.13 , pp. 3509-3514
    • Biswas, R.1    Vonderhaar, B.K.2
  • 9
    • 67349104572 scopus 로고    scopus 로고
    • Complex prolactin crosstalk in breast cancer: New therapeutic implications
    • Carver KC, Arendt LM, Schuler LA (2009) Complex prolactin crosstalk in breast cancer: new therapeutic implications. Mol Cell Endocrinol 307: 1-7
    • (2009) Mol Cell Endocrinol , vol.307 , pp. 1-7
    • Carver, K.C.1    Arendt, L.M.2    Schuler, L.A.3
  • 10
    • 77950873516 scopus 로고    scopus 로고
    • Prolactin enhances insulin-like growth factor i receptor phosphorylation by decreasing its association with the tyrosine phosphatase SHP-2 in MCF-7 breast cancer cells
    • Carver KC, Piazza TM, Schuler LA (2010) Prolactin enhances insulin-like growth factor I receptor phosphorylation by decreasing its association with the tyrosine phosphatase SHP-2 in MCF-7 breast cancer cells. J Biol Chem 285: 8003-8012
    • (2010) J Biol Chem , vol.285 , pp. 8003-8012
    • Carver, K.C.1    Piazza, T.M.2    Schuler, L.A.3
  • 11
    • 4444255613 scopus 로고    scopus 로고
    • Role of prolactin/prolactin receptor signaling in human breast cancer
    • Clevenger CV (2003) Role of prolactin/prolactin receptor signaling in human breast cancer. Breast Dis 18: 75-86 (Pubitemid 39193333)
    • (2003) Breast Disease , vol.18 , pp. 75-86
    • Clevenger, C.V.1
  • 13
    • 40249111487 scopus 로고    scopus 로고
    • From bench to bedside: Future potential for the translation of prolactin inhibitors as breast cancer therapeutics
    • Clevenger CV, Zheng J, Jablonski EM, Galbaugh TL, Fang F (2008) From bench to bedside: future potential for the translation of prolactin inhibitors as breast cancer therapeutics. J Mammary Gland Biol Neoplasia 13: 147-156
    • (2008) J Mammary Gland Biol Neoplasia , vol.13 , pp. 147-156
    • Clevenger, C.V.1    Zheng, J.2    Jablonski, E.M.3    Galbaugh, T.L.4    Fang, F.5
  • 14
    • 77953436551 scopus 로고    scopus 로고
    • Stat5 promotes survival of mammary epithelial cells through transcriptional activation of a distinct promoter in Akt1
    • Creamer BA, Sakamoto K, Schmidt JW, Triplett AA, Moriggl R, Wagner KU (2010) Stat5 promotes survival of mammary epithelial cells through transcriptional activation of a distinct promoter in Akt1. Mol Cell Biol 30: 2957-2970
    • (2010) Mol Cell Biol , vol.30 , pp. 2957-2970
    • Creamer, B.A.1    Sakamoto, K.2    Schmidt, J.W.3    Triplett, A.A.4    Moriggl, R.5    Wagner, K.U.6
  • 16
    • 40949103423 scopus 로고    scopus 로고
    • Transcription factor signal transducer and activator of transcription 5 promotes growth of human prostate cancer cells in vivo
    • DOI 10.1158/1078-0432.CCR-07-2024
    • Dagvadorj A, Kirken RA, Leiby B, Karras J, Nevalainen MT (2008) Transcription factor signal transducer and activator of transcription 5 promotes growth of human prostate cancer cells in vivo. Clin Cancer Res 14: 1317-1324 (Pubitemid 351413910)
    • (2008) Clinical Cancer Research , vol.14 , Issue.5 , pp. 1317-1324
    • Dagvadorj, A.1    Kirken, R.A.2    Leiby, B.3    Karras, J.4    Nevalainen, M.T.5
  • 17
    • 34547820916 scopus 로고    scopus 로고
    • Prolactin upregulates sphingosine kinase-1 expression and activity in the human breast cancer cell line MCF7 and triggers enhanced proliferation and migration
    • DOI 10.1677/ERC-06-0050
    • Doll F, Pfeilschifter J, Huwiler A (2007) Prolactin upregulates sphingosine kinase-1 expression and activity in the human breast cancer cell line MCF7 and triggers enhanced proliferation and migration. Endocr Relat Cancer 14: 325-335 (Pubitemid 47242633)
    • (2007) Endocrine-Related Cancer , vol.14 , Issue.2 , pp. 325-335
    • Doll, F.1    Pfeilschifter, J.2    Huwiler, A.3
  • 18
    • 0034454903 scopus 로고    scopus 로고
    • The roles of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormones in lymphocyte development and function: Insights from genetic models of hormone and hormone receptor deficiency
    • DOI 10.1210/er.21.3.292
    • Dorshkind K, Horseman ND (2000) The roles of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormones in lymphocyte development and function: insights from genetic models of hormone and hormone receptor deficiency. Endocr Rev 21: 292-312 (Pubitemid 32275590)
    • (2000) Endocrine Reviews , vol.21 , Issue.3 , pp. 292-312
    • Dorshkind, K.1    Horseman, N.D.2
  • 19
    • 67349193700 scopus 로고    scopus 로고
    • Prolactin and the skin: A dermatological perspective on an ancient pleiotropic peptide hormone
    • Foitzik K, Langan EA, Paus R (2009) Prolactin and the skin: a dermatological perspective on an ancient pleiotropic peptide hormone. J Invest Dermatol 129: 1071-1087
    • (2009) J Invest Dermatol , vol.129 , pp. 1071-1087
    • Foitzik, K.1    Langan, E.A.2    Paus, R.3
  • 20
    • 0029012232 scopus 로고
    • Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines
    • Fuh G, Wells JA (1995) Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines. J Biol Chem 270: 13133-13137
    • (1995) J Biol Chem , vol.270 , pp. 13133-13137
    • Fuh, G.1    Wells, J.A.2
  • 23
    • 51149123494 scopus 로고    scopus 로고
    • Adverse effects of prolactin in rodents and humans: Breast and prostate cancer
    • Harvey PW, Everett DJ, Springall CJ (2008) Adverse effects of prolactin in rodents and humans: breast and prostate cancer. J Psychopharmacol 22: 20-27
    • (2008) J Psychopharmacol , vol.22 , pp. 20-27
    • Harvey, P.W.1    Everett, D.J.2    Springall, C.J.3
  • 27
    • 65849450483 scopus 로고    scopus 로고
    • Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity
    • Howell SJ, Anderson E, Hunter T, Farnie G, Clarke RB (2008) Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity. Breast Cancer Res 10: R68
    • (2008) Breast Cancer Res , vol.10
    • Howell, S.J.1    Anderson, E.2    Hunter, T.3    Farnie, G.4    Clarke, R.B.5
  • 29
    • 17744378741 scopus 로고    scopus 로고
    • Development of a prolactin receptor-targeting fusion toxin using a prolactin antagonist and a recombinant form of Pseudomonas exotoxin A
    • DOI 10.1007/s10549-004-4816-9
    • Langenheim JF, Chen WY (2005) Development of a prolactin receptor-targeting fusion toxin using a prolactin antagonist and a recombinant form of Pseudomonas exotoxin A. Breast Cancer Res Treat 90: 281-293 (Pubitemid 40576842)
    • (2005) Breast Cancer Research and Treatment , vol.90 , Issue.3 , pp. 281-293
    • Langenheim, J.F.1    Chen, W.Y.2
  • 31
    • 0028858647 scopus 로고
    • Constitutive production of IL-2 by human carcinoma cells, expression of IL-2 receptor, and tumor cell growth
    • Lin WC, Yasumura S, Suminami Y, Sung MW, Nagashima S, Stanson J, Whiteside TL (1995) Constitutive production of IL-2 by human carcinoma cells, expression of IL-2 receptor, and tumor cell growth. J Immunol 155: 4805-4816
    • (1995) J Immunol , vol.155 , pp. 4805-4816
    • Lin, W.C.1    Yasumura, S.2    Suminami, Y.3    Sung, M.W.4    Nagashima, S.5    Stanson, J.6    Whiteside, T.L.7
  • 32
    • 42549096464 scopus 로고    scopus 로고
    • Altered expression of prolactin receptor-associated signaling proteins in human breast carcinoma
    • DOI 10.1038/modpathol.2008.7, PII MODPATHOL20087
    • McHale K, Tomaszewski JE, Puthiyaveettil R, Livolsi VA, Clevenger CV (2008) Altered expression of prolactin receptor-associated signaling proteins in human breast carcinoma. Mod Pathol 21: 565-571 (Pubitemid 351589663)
    • (2008) Modern Pathology , vol.21 , Issue.5 , pp. 565-571
    • McHale, K.1    Tomaszewski, J.E.2    Puthiyaveettil, R.3    Livolsi, V.A.4    Clevenger, C.V.5
  • 35
    • 0028301308 scopus 로고
    • Circulating prolactin and tumoral prolactin receptors in men with tongue cancer: A preliminary study
    • Patel DD, Bhatavdekar JM, Vora HH, Balar DB (1994) Circulating prolactin and tumoral prolactin receptors in men with tongue cancer: a preliminary study. Eur J Surg Oncol 20: 155-159 (Pubitemid 24164471)
    • (1994) European Journal of Surgical Oncology , vol.20 , Issue.2 , pp. 155-159
    • Patel, D.D.1    Bhatavdekar, J.M.2    Vora, H.H.3    Balar, D.B.4
  • 37
    • 66149095511 scopus 로고    scopus 로고
    • Impaired turnover of prolactin receptor contributes to transformation of human breast cells
    • Plotnikov A, Varghese B, Tran TH, Liu C, Rui H, Fuchs SY (2009) Impaired turnover of prolactin receptor contributes to transformation of human breast cells. Cancer Res 69: 3165-3172
    • (2009) Cancer Res , vol.69 , pp. 3165-3172
    • Plotnikov, A.1    Varghese, B.2    Tran, T.H.3    Liu, C.4    Rui, H.5    Fuchs, S.Y.6
  • 39
    • 0033330658 scopus 로고    scopus 로고
    • Differentiation-dependent prolactin responsiveness and stat (signal transducers and activators of transcription) signaling in rat ovarian cells
    • Russell DL, Richards JS (1999) Differentiation-dependent prolactin responsiveness and stat (signal transducers and activators of transcription) signaling in rat ovarian cells. Mol Endocrinol 13: 2049-2064 (Pubitemid 30637266)
    • (1999) Molecular Endocrinology , vol.13 , Issue.12 , pp. 2049-2064
    • Russell, D.L.1    Richards, J.S.2
  • 40
    • 40249102092 scopus 로고    scopus 로고
    • Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells
    • Scotti ML, Langenheim JF, Tomblyn S, Springs AE, Chen WY (2008) Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells. Breast Cancer Res Treat 111: 241-250
    • (2008) Breast Cancer Res Treat , vol.111 , pp. 241-250
    • Scotti, M.L.1    Langenheim, J.F.2    Tomblyn, S.3    Springs, A.E.4    Chen, W.Y.5
  • 41
    • 67649438663 scopus 로고    scopus 로고
    • Combination therapy using three novel prolactin receptor antagonist-based fusion proteins effectively inhibits tumor recurrence and metastasis in HER2/ neu transgenic mice
    • Tomblyn S, Springs AE, Langenheim JF, Chen WY (2009) Combination therapy using three novel prolactin receptor antagonist-based fusion proteins effectively inhibits tumor recurrence and metastasis in HER2/ neu transgenic mice. Int J Oncol 34: 1139-1146
    • (2009) Int J Oncol , vol.34 , pp. 1139-1146
    • Tomblyn, S.1    Springs, A.E.2    Langenheim, J.F.3    Chen, W.Y.4
  • 42
    • 34248190678 scopus 로고    scopus 로고
    • A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer
    • DOI 10.1200/JCO.2006.07.6356
    • Tworoger SS, Eliassen AH, Sluss P, Hankinson SE (2007) A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. J Clin Oncol 25: 1482-1488 (Pubitemid 46733075)
    • (2007) Journal of Clinical Oncology , vol.25 , Issue.12 , pp. 1482-1488
    • Tworoger, S.S.1    Eliassen, A.H.2    Sluss, P.3    Hankinson, S.E.4
  • 43
    • 40249102994 scopus 로고    scopus 로고
    • Prolactin and breast cancer etiology: An epidemiologic perspective
    • Tworoger SS, Hankinson SE (2008) Prolactin and breast cancer etiology: an epidemiologic perspective. J Mammary Gland Biol Neoplasia 13: 41-53
    • (2008) J Mammary Gland Biol Neoplasia , vol.13 , pp. 41-53
    • Tworoger, S.S.1    Hankinson, S.E.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.